iSpecimen (ISPC) EGM 2026 summary

Opening remarks and agenda

• Reconvened session began Oct. 30, 2026, to address only proposal 2; proposals 1, 3, 4 and 5 were acted on Oct. 9, 2026.

• No other business was scheduled; the meeting was adjourned after the vote on proposal 2.

Specific resolutions to be voted on

• Proposal 2 sought an amendment to the certificate of incorporation authorizing a 1-for-10 to 1-for-100 reverse split of outstanding common shares, with the board setting the exact ratio without further stockholder approval.

• Approval required votes cast for the proposal to exceed votes cast against; abstentions had no effect, and brokers could vote uninstructed shares at their discretion.

Board and executive committee updates

• The board unanimously recommended voting for proposal 2 and had determined the proposal’s voting standard by unanimous written consent on Oct. 9, 2026.